American Century Companies’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

American Century Companies's LKFT Position: Q2 2026 in Review

American Century Companies increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 5.2% in Q2 2026, buying an estimated $57.2K and bringing the position to 40,804 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #2351.

American Century Companies first reported a position in LKFT in Q1 2020 and has held it in 21 quarters since. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

• American Century Companies held 40,804 shares of Lakefront Biotherapeutics American Depositary Shares worth $1.22M as of Q2 2026.
• American Century Companies bought 2,014 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $57.2K.
• Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2351 holding.
• American Century Companies first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2020 and has held it in 21 quarters since.
• 76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.